{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:17:59Z","timestamp":1752283079208},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,11,27]],"date-time":"2010-11-27T00:00:00Z","timestamp":1290816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11033-010-0555-7","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T14:40:38Z","timestamp":1290782438000},"page":"4309-4313","source":"Crossref","is-referenced-by-count":16,"title":["Association between N142D genetic polymorphism of GSTO2 and susceptibility to colorectal cancer"],"prefix":"10.1007","volume":"38","author":[{"given":"Mohammad","family":"Masoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahpour","family":"Omidvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,27]]},"reference":[{"key":"555_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51\u201388","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"555_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0027-5107(88)90197-2","volume":"202","author":"B Ketterer","year":"1988","unstructured":"Ketterer B (1988) The protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202:343\u2013361","journal-title":"Mutat Res"},{"key":"555_CR3","doi-asserted-by":"crossref","first-page":"24798","DOI":"10.1074\/jbc.M001706200","volume":"275","author":"PG Board","year":"2000","unstructured":"Board PG, Coggan M, Chelvanayagam G et al (2000) Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 275:24798\u201324806","journal-title":"J Biol Chem"},{"key":"555_CR4","first-page":"19","volume":"16","author":"L Wang","year":"2005","unstructured":"Wang L, Xu J, Ji C et al (2005) Cloning, expression and characterization of human glutathione S-transferase omega 2. Int J Mol Med 16:19\u201327","journal-title":"Int J Mol Med"},{"key":"555_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1021\/tx010052h","volume":"14","author":"RA Zakharyan","year":"2001","unstructured":"Zakharyan RA, Sampayo-Reyes A, Healy SM et al (2001) Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14:1051\u20131057","journal-title":"Chem Res Toxicol"},{"key":"555_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008571-200303000-00003","volume":"13","author":"AK Whitbread","year":"2003","unstructured":"Whitbread AK, Tetlow N, Eyre HJ et al (2003) Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131\u2013144","journal-title":"Pharmacogenetics"},{"key":"555_CR7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1124\/dmd.106.009613","volume":"34","author":"B Mukherjee","year":"2006","unstructured":"Mukherjee B, Salavaggione OE, Pelleymounter LL et al (2006) Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 34:1237\u20131246","journal-title":"Drug Metab Dispos"},{"key":"555_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.2008.05058.x","volume":"36","author":"H Takeshita","year":"2009","unstructured":"Takeshita H, Fujihara J, Takastuka H et al (2009) Diversity of glutathione S-transferase omega 1 (A140D) and 2 (N142D) gene polymorphisms in worldwide populations. Clin Exp Pharmacol Physiol 36:283\u2013286","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"555_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11033-009-9565-8","volume":"37","author":"L Rafiee","year":"2010","unstructured":"Rafiee L, Saadat I, Saadat M (2010) Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 37:155\u2013158","journal-title":"Mol Biol Rep"},{"key":"555_CR10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pros.20907","volume":"69","author":"Z Mo","year":"2009","unstructured":"Mo Z, Gao Y, Cao Y et al (2009) An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a Huge review. Prostate 69:662\u2013688","journal-title":"Prostate"},{"key":"555_CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1349-7006.2006.00207.x","volume":"97","author":"M Saadat","year":"2006","unstructured":"Saadat M (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97:505\u2013509","journal-title":"Cancer Sci"},{"key":"555_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/07357900802146170","volume":"27","author":"W Zhuo","year":"2009","unstructured":"Zhuo W, Wang Y, Zhuo X et al (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27:86\u201395","journal-title":"Cancer Invest"},{"key":"555_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11033-009-9673-5","volume":"37","author":"J Altinisik","year":"2010","unstructured":"Altinisik J, Balta ZB, Aydin G et al (2010) Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep 37:263\u2013267","journal-title":"Mol Biol Rep"},{"key":"555_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.canlet.2005.05.020","volume":"236","author":"SB Marahatta","year":"2006","unstructured":"Marahatta SB, Punyarit P, Bhudisawasdi V et al (2006) Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett 236:276\u2013281","journal-title":"Cancer Lett"},{"key":"555_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00432-008-0501-4","volume":"135","author":"W Pongstaporn","year":"2009","unstructured":"Pongstaporn W, Pakakasama S, Sanguansin S et al (2009) Polymorphism of glutathione S-transferase omega gene: association with risk of childhood acute lymphblastic leukemia. J Cancer Res Clin Oncol 135:673\u2013678","journal-title":"J Cancer Res Clin Oncol"},{"key":"555_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4067\/S0034-98872007000300004","volume":"135","author":"JL Leite","year":"2007","unstructured":"Leite JL, Morari EC, Granja F et al (2007) Influence of the glutathione S-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma. Rev Med Chil 135:301\u2013306","journal-title":"Rev Med Chil"},{"key":"555_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11033-008-9245-0","volume":"36","author":"M Masoudi","year":"2009","unstructured":"Masoudi M, Saadat I, Omidvari S et al (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36:781\u2013784","journal-title":"Mol Biol Rep"},{"key":"555_CR18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-006-0099-3","volume":"132","author":"EC Morari","year":"2006","unstructured":"Morari EC, Lima AB, Bufalo NE et al (2006) Role of glutathione S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol 132:521\u2013528","journal-title":"J Cancer Res Clin Oncol"},{"key":"555_CR19","first-page":"107","volume":"25","author":"W Pongstaporn","year":"2006","unstructured":"Pongstaporn W, Rochanawutanon M, Wilailak S et al (2006) Genetic alterations in chromosome 10q24.3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer. J Exp Clin Cancer Res 25:107\u2013114","journal-title":"J Exp Clin Cancer Res"},{"key":"555_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-009-0521-z","volume":"120","author":"M Masoudi","year":"2010","unstructured":"Masoudi M, Saadat I, Omidvari S et al (2010) Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer. Breast Cancer Res Treat 120:263\u2013265","journal-title":"Breast Cancer Res Treat"},{"key":"555_CR21","first-page":"115","volume":"7","author":"M Masoudi","year":"2008","unstructured":"Masoudi M, Saadat M (2008) Arsenic, GSTO2 Asn142Asp polymorphism, health and treatment. EXCLI J 7:115\u2013118","journal-title":"EXCLI J"},{"key":"555_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-4608(01)00624-0","volume":"135","author":"S Struski","year":"2002","unstructured":"Struski S, Doco-Fenzy M, Cornillet-Lefebvre P (2002) Compilation of published comparative genome hybridization studies. Cancer Genet Cytogenet 135:63\u201390","journal-title":"Cancer Genet Cytogenet"},{"key":"555_CR23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.bjc.6601687","volume":"90","author":"M Karoui","year":"2004","unstructured":"Karoui M, Tresallet C, Julie C et al (2004) Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumors and metastases. Br J Cancer 90:1230\u20131234","journal-title":"Br J Cancer"},{"key":"555_CR24","first-page":"2124","volume":"85","author":"HT Zheng","year":"2005","unstructured":"Zheng HT, Peng ZH, Zhou CZ et al (2005) Refined mapping of loss heterozygosity on 10q23\u201324 in sporadic colorectal carcinoma. Zhonghua Yi Xue Za Zhi 85:2124\u20132127","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"555_CR25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11033-007-9138-7","volume":"35","author":"P Mohamadynejad","year":"2008","unstructured":"Mohamadynejad P, Saadat M (2008) Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 35:669\u2013672","journal-title":"Mol Biol Rep"},{"key":"555_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11033-007-9113-3","volume":"35","author":"M Bazrgar","year":"2008","unstructured":"Bazrgar M, Karimi M, Fathzadeh M et al (2008) Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep 35:495\u2013499","journal-title":"Mol Biol Rep"},{"key":"555_CR27","volume-title":"Clinical epidemiology: the essential","author":"RW Fletcher","year":"2005","unstructured":"Fletcher RW, Fletcher SW (2005) Clinical epidemiology: the essential, 4th edn. Lippincott Williams & Wilkins, Baltimore","edition":"4"},{"key":"555_CR28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.fpc.0000165725.81559.e3","volume":"15","author":"EM Schmuck","year":"2005","unstructured":"Schmuck EM, Board PG, Whitbread AK et al (2005) Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer\u2019s and Parkinson\u2019s diseases. Pharmacogenet Genomics 15:493\u2013501","journal-title":"Pharmacogenet Genomics"},{"key":"555_CR29","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1158\/1055-9965.EPI-04-0793","volume":"14","author":"Z Hu","year":"2005","unstructured":"Hu Z, Ma H, Chen F et al (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case\u2013control studies. Cancer Epidemiol Biomarkers Prev 14:1810\u20131818","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"555_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-008-0051-0","volume":"115","author":"M Saadat","year":"2009","unstructured":"Saadat M, Ansari-Lari M (2009) Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer: a meta-analysis of the literatures. Breast Cancer Res Treat 115:137\u2013144","journal-title":"Breast Cancer Res Treat"},{"key":"555_CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10549-010-0895-y","volume":"124","author":"M Saadat","year":"2010","unstructured":"Saadat M (2010) Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer: a meta-analysis of the literatures. Breast Cancer Res Treat 124:785\u2013791","journal-title":"Breast Cancer Res Treat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-0555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-010-0555-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-010-0555-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:04:04Z","timestamp":1559343844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-010-0555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,27]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s11033-010-0555-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,27]]}}}